Supraclavicular Versus Axillary Block for Arteriovenous (AV) Fistula Creation (CUGSCAB)
Arteriovenous Fistula, Brachial Plexus Block, Clinical Efficacy
About this trial
This is an interventional treatment trial for Arteriovenous Fistula focused on measuring Arteriovenous fistula, brachial plexus block, ultrasound guided, complications, block recovery
Eligibility Criteria
Inclusion Criteria: Age >18 years old Patients undergoing AV fistula creation in the antecubital fossa Exclusion Criteria: - Patient Refusal Hemodynamically unstable patient Local infection over the insertion site Coagulopathy Known allergy to Local Anaesthetic medications Abnormal anatomy Use of antiplatelet within 7 days of surgery
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Supraclavicular block
Axillary block
In the supraclavicular group, the ultrasound probe will be positioned in the supraclavicular fossa, pointing caudad and locating the subclavian artery. The first rib is identified deep to the artery, and the hyperechoic pleura will be identified by sliding lung sign. The brachial plexus is consistently found with a characteristic ''honeycomb'' appearance lateral and superficial to the subclavian artery and superior to the first rib. The needle will be introduced through the skin from lateral to medial, in-plane with the transducer, with constant visualization, and directed toward the deep border of the nerve group. Three separate injections will be made at various sites in the bundle, tending to start deep, in the ''corner pocket'' close to the artery, and moving more superficially. The local anesthetics will be Lidocaine 2% 10 ml + Levobupivacaine 0.5% 10 ml.
Patients in the axillary group are placed in the supine position with the arm to be blocked, abducted and externally rotated. After sterilization of the axilla, the Ultrasound probe will be placed parallel to the anterior axillary fold at the axilla to identify the axillary artery and surrounding radial, ulnar, and median nerve, appearing as hypo-echoic round structures around the axillary artery. The musculocutaneous nerve will also be identified between the coracobrachialis and biceps muscle or in either of them. Lidocaine 1% was infiltrated subcutaneously 1 cm lateral to the probe, and then 0.5% bupivacaine will be injected around branches of the brachial plexus. The local anesthetics will be Lidocaine 2% 10 ml + Levobupivacaine 0.5% 15 ml. In this block, 5-7 ml of local anesthetic will block each nerve.